Skip to content
OpenCapital
Get started

Vericel VCEL Free cash flow

Free cash flow at other companies

Stryker logo
StrykerSYK
$415M+227%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$12.31M+60.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.47B-56.6%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
——
Globus Medical logo
Globus MedicalGMED
——

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%—

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Calculated from Vericel’s reported figures.

$16.4Mnet cash from operating−$1.3Mcapital expenditures=$15.13M

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's free cash flow?
Vericel (VCEL) reported free cash flow of $15.13M in Q1 2026.
How has Vericel's free cash flow changed year-over-year?
Vericel's free cash flow increased by 298.7% year-over-year, from -$7.61M to $15.13M.
What is the long-term trend for Vericel's free cash flow?
Over 3 years (2021 to 2025), Vericel's free cash flow has grown at a 5.4% compound annual growth rate (CAGR), from $21.13M to $24.75M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.